Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.68%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
-
Rhea-AI Summary
GlucoTrack (NASDAQ:GCTK) filed an 8-K announcing the issuance of a press release on June 25, 2025. However, the actual content of the press release is not included in this filing. The 8-K serves only as a notice under Regulation FD that a press release was issued and is being furnished as Exhibit 99.1. The filing was signed by Paul Goode, Chief Executive Officer.
The actual material information or substance of the press release cannot be analyzed as it is not provided in this filing.Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.25%
Tags
FAQ
How many Glucotrack (GCTK) SEC filings are available on StockTitan?
StockTitan tracks 85 SEC filings for Glucotrack (GCTK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Glucotrack (GCTK)?
The most recent SEC filing for Glucotrack (GCTK) was filed on July 31, 2025.